183 related articles for article (PubMed ID: 38244583)
1.
Kong W; Liu X; Zhu H; Zheng S; Yin G; Yu P; Shan Y; Ma S; Ying R; Jin H
Aging (Albany NY); 2024 Jan; 16(2):1767-1780. PubMed ID: 38244583
[TBL] [Abstract][Full Text] [Related]
2. EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer.
Soldan SS; Anderson EM; Frase DM; Zhang Y; Caruso LB; Wang Y; Deakyne JS; Gewurz BE; Tempera I; Lieberman PM; Messick TE
Gastric Cancer; 2021 Sep; 24(5):1076-1088. PubMed ID: 33929613
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.
Bai Y; Xie T; Wang Z; Tong S; Zhao X; Zhao F; Cai J; Wei X; Peng Z; Shen L
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35241494
[TBL] [Abstract][Full Text] [Related]
4. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3.
Asakawa Y; Okabe A; Fukuyo M; Li W; Ikeda E; Mano Y; Funata S; Namba H; Fujii T; Kita K; Matsusaka K; Kaneda A
Cancer Sci; 2020 May; 111(5):1818-1828. PubMed ID: 32119176
[TBL] [Abstract][Full Text] [Related]
6. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma.
Choi SJ; Shin YS; Kang BW; Kim JG; Won KJ; Lieberman PM; Cho H; Kang H
Arch Pharm Res; 2017 Aug; 40(8):894-905. PubMed ID: 28779374
[TBL] [Abstract][Full Text] [Related]
7. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J
Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of circulating cell-free Epstein-Barr virus DNA in patients with gastric cancer.
Shoda K; Ichikawa D; Fujita Y; Masuda K; Hiramoto H; Hamada J; Arita T; Konishi H; Kosuga T; Komatsu S; Shiozaki A; Okamoto K; Imoto I; Otsuji E
Oncotarget; 2017 Apr; 8(17):28796-28804. PubMed ID: 28430637
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori and Epstein-Barr Virus Coinfection Stimulates Aggressiveness in Gastric Cancer through the Regulation of Gankyrin.
Kashyap D; Baral B; Jakhmola S; Singh AK; Jha HC
mSphere; 2021 Oct; 6(5):e0075121. PubMed ID: 34585958
[TBL] [Abstract][Full Text] [Related]
11. Determination and genome-wide analysis of Epstein-Barr virus (EBV) sequences in EBV-associated gastric carcinoma from Guangdong, an endemic area of nasopharyngeal carcinoma.
Chen JN; Zhou L; Qiu XM; Yang RH; Liang J; Pan YH; Li HF; Peng GR; Shao CK
J Med Microbiol; 2018 Nov; 67(11):1614-1627. PubMed ID: 30239329
[TBL] [Abstract][Full Text] [Related]
12. The Role of LMP1 in Epstein-Barr Virus-associated Gastric Cancer.
Huang X; Zhang M; Zhang Z
Curr Cancer Drug Targets; 2024; 24(2):127-141. PubMed ID: 37183458
[TBL] [Abstract][Full Text] [Related]
13. P53 deregulation in Epstein-Barr virus-associated gastric cancer.
Ribeiro J; Malta M; Galaghar A; Silva F; Afonso LP; Medeiros R; Sousa H
Cancer Lett; 2017 Sep; 404():37-43. PubMed ID: 28729047
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.
Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W
Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and characteristics of Epstein-Barr virus associated gastric carcinoma in Gansu Province, Northwest China with mRNA expression of glycoprotein BMRF2.
Guo C; Wei J; Scott RS; Chen Y; Chen Z; Zhao W; Zhang C; Wang B; Chai C; Dai G; Li M; Zhang F
J Med Virol; 2020 Mar; 92(3):356-363. PubMed ID: 31663617
[TBL] [Abstract][Full Text] [Related]
16. Status of kinases in Epstein-Barr virus and Helicobacter pylori Coinfection in gastric Cancer cells.
Sonkar C; Verma T; Chatterji D; Jain AK; Jha HC
BMC Cancer; 2020 Sep; 20(1):925. PubMed ID: 32993565
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC).
Liu Y; Yang W; Pan Y; Ji J; Lu Z; Ke Y
Oncotarget; 2016 Jan; 7(4):4903-14. PubMed ID: 26716899
[TBL] [Abstract][Full Text] [Related]
18. Expression of MAP9 in Epstein-Barr virus-associated gastric carcinoma.
Xiao H; Sun J; Huang W; Liu W; Zhang Y; Wang H; Luo B
Virus Res; 2021 Feb; 293():198253. PubMed ID: 33309912
[TBL] [Abstract][Full Text] [Related]
19. Quercetin induces ferroptosis in gastric cancer cells by targeting SLC1A5 and regulating the p-Camk2/p-DRP1 and NRF2/GPX4 Axes.
Ding L; Dang S; Sun M; Zhou D; Sun Y; Li E; Peng S; Li J; Li G
Free Radic Biol Med; 2024 Mar; 213():150-163. PubMed ID: 38190923
[TBL] [Abstract][Full Text] [Related]
20. EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma.
Yuan L; Li S; Chen Q; Xia T; Luo D; Li L; Liu S; Guo S; Liu L; Du C; Jia G; Li X; Lu Z; Yang Z; Liu H; Mai H; Tang L
Cell Death Differ; 2022 Aug; 29(8):1513-1527. PubMed ID: 35105963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
